Stay updated with breaking news from Philippa Salter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
18 Apr, 2024 Despite positive efficacy data highlighted at AAN 2024, Axsome Therapeutic's ASX-07 will struggle to make significant impact in acute migraine market, says GlobalData ...
08 Mar, 2024 TauRx's HMTM could become first oral DMT targeting Tau for Alzheimer's disease, says GlobalData Share Print...
Relmada Therapeutics, Inc. has announced rapid and sustained effects of an anti-depressant in patients with major depressive disorders (MDD).
10 Jul, 2023 Blockbuster status for Leqembi expected following full FDA approval, says GlobalData Share Print page ...
The Alzheimer's disease market is projected to experience robust growth at a compound annual growth rate of 20 per cent from $2.2 billion in 2020 to $13.7 billion in 2030, according to a report on Wednesday.The growth will be particularly seen ...